Applied DNA stock jumps amid U.S. government mpox update
by
Contributor since / Followers
Contributor since / Followers
4 months ago
JUN LI
- Applied DNA Sciences (NASDAQ:APDN) shares rose 17% in afternoon trading Friday after U.S. officials said the government was stepping up surveillance of the mpox virus in response to an ongoing outbreak in Africa.
- Also rising were shares of fellow mpox test maker Co-Diagnostics (NASDAQ:CODX), which edged up 2%.
- Other makers of mpox detection products include Abbott (ABT) and Roche (OTCQX:RHHBY).
- Earlier Friday, U.S. officials said during a briefing that the government was expanding surveillance along with access to mpox testing and vaccines amid an ongoing outbreak of the disease overseas. It added that no new cases of a more easily transmissible strain of the virus have been confirmed in the U.S., according to Reuters.
- Mpox, which is related to smallpox, is also known as monkeypox.